Glycine Transporter-1: A New Potential Therapeutic Target for Schizophrenia

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|2|112-120

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.2, 2011-01, pp. : 112-120

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glycine Reuptake Inhibition as a New Therapeutic Approach in Schizophrenia: Focus on the Glycine Transporter 1 (GlyT1)

By  

Current Pharmaceutical Design, Vol. 19, Iss. 7, 2013-02 ,pp. : 1311-1320

Bentham Science Publishers

Access to resources Recommend Favorite

The therapeutic potential of glycine transporter-1 inhibitors

By Sur Cyrille   Kinney Gene G  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 5, 2004-05 ,pp. : 515-521

Informa Healthcare

Access to resources Recommend Favorite

Glycine Transporter-1 Inhibitors as Novel Therapeutic Drugs for Schizophrenia

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 7, Iss. 3, 2007-09 ,pp. : 177-182

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of glycine transporter 1: The yellow brick road to new schizophrenia therapy?

By  

Current Pharmaceutical Design, Vol. 21, Iss. 26, 2015-01 ,pp. : 3771-3787

Bentham Science Publishers

Access to resources Recommend Favorite

Glycine Site Modulators and Glycine Transporter-1 Inhibitors as Novel Therapeutic Targets for the Treatment of Schizophrenia

By  

Current Neuropharmacology, Vol. 3, Iss. 1, 2005-01 ,pp. : 35-43

Bentham Science Publishers

Access to resources Recommend Favorite